Jazz Pharmaceuticals's market cap is currently $7.90B. The company's EPS TTM is $-8.25; its P/E ratio is 15.58; Jazz Pharmaceuticals is scheduled to report earnings on August 5, 2025, and the estimated EPS forecast is $5.96. See an overview of income statement, balance sheet, and cash flow financials.
